Vital Signs - Recent Advancements in Drug Delivery  Novel Formulations and Technologies Offer Improved Treatment Options

 

Regular Price: USD 1,500

Special Price USD 1,125

25% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,125

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on August 13, 2012, provides an insight in to the recent advancements in drug delivery.

Additionally, a company spotlight is provided for Ratio. Ratio, Inc. is a start-up company focused on the development of a novel hydrogel-powered injectable drug delivery device that is worn like a patch. Reimbursement and regulatory news from the FDA is also provided for week of July 30, 2012.

Table of Contents

Vital Signs - Recent Advancements in Drug Delivery – Novel Formulations and Technologies Offer Improved Treatment OptionsVital Signs: 13 August 2012This week's issue




Related Research

Release Date : 08-Sep-17

Region : North America

Release Date : 22-Aug-17

Region : North America

Release Date : 08-Aug-17

Region : North America

Release Date : 31-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.